Kostas Drosopoulos Joins the Team Full Time

Dr Drosopoulos is a seasoned professional with a strong background in drug discovery and target ID. With extensive experience in identifying and validating drug targets, Kostas has successfully worked with cross-functional teams and managed partnerships with leading pharmaceutical companies. Prior to joining Chromatin Bioscience in 2024, he worked as a Staff Scientist at the Institute of Cancer Research, where he contributed to multiple projects in cancer therapeutics. Now, as Director of Business Development at Chromatin Bioscience, Kostas leverages his scientific expertise and industry insights to foster strategic collaborations and and drive the application of Chromatin Bioscience’s innovative synthetic promoters, designed to elevate the safety, efficacy, and bioprocessing efficiency of our partners' therapeutic developments.